Erratum to Probiotic Preparation Duolac-Gold Ameliorates Dextran Sulphate Sodium-induced Mouse Colitis by Downregulating the Expression of IL-6 [Toxicological Research, 30, 1, (2014) 27-32] 10.5487/TR.2014.30.1.027;A probiotic preparation duolac-gold ameliorates dextran sulphate sodium-induced mouse colitis by downregulating the expression of IL-6

Toxicological Research

Volumn 30, Issue 1, 2014, Pages 27-32

  Yoon, Hyunho ^a   Yoon, Yeo Sang ^a   Kim, Min Soo ^a   Chung, Myung Jun ^a   Yum, Do Young ^a  

^a R D Center Cellbiotech Co Ltd   (South Korea)

Author keywords

Cytokines; Duolac gold; Inflammatory bowel disease; Interleukin 6; Probiotics

Indexed keywords

EID: 84902972002     PISSN: 19768257     EISSN: 22342753     Source Type: Journal    
DOI: 10.5487/TR.2014.30.2.139     Document Type: Erratum

References (30)

1. Bai, A.P. and Ouyang, Q. (2006) Probiotics and inflammatory bowel diseases. Postgrad. Med. J., 82, 376-382.
2. Stein, J., Hartmann, F. and Dignass, A.U. (2010) Diagnosis and management of iron deficiency anemia in patients with IBD. Nat. Rev. Gastroenterol. Hepatol., 7, 599-610.
3. Kaser, A., Zeissig, S. and Blumberg, R.S. (2010) Inflammatory bowel disease. Annu. Rev. Immunol., 28, 573-621.
4. Rogler, G. and Andus, T. (1998) Cytokines in inflammatory bowel disease. World J. Surg., 22, 382-389.
5. Atreya, R., Mudter, J., Finotto, S., Mullberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., Strand, D., Czaja, J., Schlaak, J.F., Lehr, H.A., Autschbach, F., Schürmann, G., Nishimoto, N., Yoshizaki, K., Ito, H., Kishimoto, T., Galle, P.R., Rose-John, S. and Neurath, M.F. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med., 6, 583-588.
6. Shen, D., Liu, C., Xu, R. and Zhang, F. (2012) Human gut microbiota: dysbiosis and manipulation. Front. Cell. Infect. Microbiol., 2, 123.
7. de Vos, W.M. and de Vos, E.A. (2012) Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev., 70 Suppl 1, S45-56.
8. Abraham, C. and Medzhitov, R. (2011) Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology, 140, 1729-1737.
9. Bien, J., Palagani, V. and Bozko, P. (2013) The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Ther. Adv. Gastroenterol., 6, 53-68.
10. Walker, A.W. and Lawley, T.D. (2013) Therapeutic modulation of intestinal dysbiosis. Pharmacol. Res., 69, 75-86.
11. Uccello, M., Malaguarnera, G., Basile, F., D'Agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F. and Biondi, A. (2012) Potential role of probiotics on colorectal cancer prevention. BMC Surg., 12 Suppl 1, S35.
12. Ouwehand, A.C., Salminen, S. and Isolauri, E. (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek, 82, 279-289.
13. Salminen, S., Bouley, C., Boutron-Ruault, M.C., Cummings, J.H., Franck, A., Gibson, G.R., Isolauri, E., Moreau, M.C., Roberfroid, M. and Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr., 80 Suppl 1, S147-171.
14. Sang, L.X., Chang, B., Zhang, W.L., Wu, X.M., Li, X.H. and Jiang, M. (2010) Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J. Gastroenterol., 16, 1908-1915.
15. Lee, J.S., Chung, M.J. and Seo, J.G. (2013) In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria against Clostridium difficile. Toxicol. Res., 29, 99-106.
16. Miyauchi, E., Ogita, T., Miyamoto, J., Kawamoto, S., Morita, H., Ohno, H., Suzuki, T. and Tanabe, S. (2013) Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules. PLoS One, 8, e79735.
17. Matsumoto, Y. (2005) New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines. Curr. Drug Targets Immune Endocr. Metab. Disord., 5, 73-77.
18. Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G. and Xia, B. (2014) Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrateproducing bacteria in inflammatory bowel disease. J. Clin. Microbiol., 52, 398-406.
19. MacPherson, B.R. and Pfeiffer, C.J. (1978) Experimental production of diffuse colitis in rats. Digestion, 17, 135-150.
20. Strober, W., Fuss, I.J. and Blumberg, R.S. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol., 20, 495-549.
21. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694-702.
22. Hyun, E., Andrade-Gordon, P., Steinhoff, M. and Vergnolle, N. (2008) Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut, 57, 1222-1229.
23. Baumgart, D.C. and Sandborn, W.J. (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet, 369, 1641-1657.
24. Cooper, H.S., Murthy, S.N., Shah, R.S. and Sedergran, D.J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest., 69, 238-249.
25. Hedger, M.P. and Meinhardt, A. (2003) Cytokines and the immune-testicular axis. J. Reprod. Immunol., 58, 1-26.
26. Eming, S.A., Kaufmann, J., Löhrer, R. and Krieg, T. (2007) [Chronic wounds. Novel approaches in research and therapy]. Hautarzt, 58, 939-944.
27. Guha, M., O'Connell, M.A., Pawlinski, R., Hollis, A., McGovern, P., Yan, S.F., Stern, D. and Mackman, N. (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood, 98, 1429-1439.
28. D'Aiuto, F., Parkar, M., Brett, P.M., Ready, D. and Tonetti, M.S. (2004) Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine, 28, 29-34.
29. Cronstein, B.N. and Terkeltaub, R. (2006) Interleukin-6 and chronic inflammation. Arthritis Res. Ther., 8 Suppl 1, S3.
30. Dieleman, L. and Hoentjen, F. (2012) [Probiotics have a limited role in the treatment of inflammatory bowel disease]. Ned. Tijdschr. Geneeskd., 156, A5206.